Back to
UBS Group AG
ARTV8 quarters
Position history for
UBS Group AG's holdings in ARTIVA BIOTHERAPEUTICS INC
Yes. Ubs holds 184,020 shares of ARTV (Artiva Biotherapeutics), worth $1.8M, as of its Q2 2026 13F filing. It increased the position from 1,527 shares in Q1 2026. Ubs has held ARTV in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$1.8M
Current Shares
184,020
Total Value Change
+$1.7M
Total Shares Change
+177,402
Quarter-by-Quarter History
Other major holders of ARTV: RA CAPITAL MANAGEMENT, L.P.